Growth Metrics

Mannkind (MNKD) Assets Growth (1y) (2011 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn -
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn -
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn
7 Evaxion A 62.56 Bn 62.54 Bn -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn
10 Mannkind 1.09 Bn 956.66 Mn 82.66 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 81.50%
Dec 31, 2025 101.14%
Sep 30, 2025 6.56%
Jun 30, 2025 -7.24%
Mar 31, 2025 -14.71%
Dec 31, 2024 -17.12%
Sep 30, 2024 44.91%
Jun 30, 2024 41.61%
Mar 31, 2024 61.29%
Dec 31, 2023 60.93%
Sep 30, 2023 9.02%
Jun 30, 2023 9.67%
Mar 31, 2023 -3.30%
Dec 31, 2022 -8.06%
Sep 30, 2022 23.35%
Jun 30, 2022 13.06%
Mar 31, 2022 -3.46%
Dec 31, 2021 195.71%
Sep 30, 2021 148.96%
Jun 30, 2021 145.95%
Mar 31, 2021 298.17%
Dec 31, 2020 15.88%
Sep 30, 2020 0.57%
Jun 30, 2020 25.66%
Mar 31, 2020 -20.55%
Dec 31, 2019 -12.98%
Sep 30, 2019 109.76%
Jun 30, 2019 31.60%
Mar 31, 2019 63.16%
Dec 31, 2018 27.35%
Sep 30, 2018 -19.70%
Jun 30, 2018 -21.69%
Mar 31, 2018 -27.36%
Dec 31, 2017 -21.00%
Sep 30, 2017 -41.24%
Jun 30, 2017 -43.07%
Mar 31, 2017 -8.67%
Dec 31, 2016 -15.31%
Sep 30, 2016 -65.42%
Jun 30, 2016 -60.45%
Mar 31, 2016 -74.09%
Dec 31, 2015 -67.95%
Sep 30, 2015 -28.13%
Jun 30, 2015 49.19%
Mar 31, 2015 60.33%
Dec 31, 2014 52.50%
Sep 30, 2014 34.49%
Jun 30, 2014 11.24%
Mar 31, 2014 4.35%
Dec 31, 2013 2.92%
Sep 30, 2013 36.74%
Jun 30, 2013 -11.63%
Mar 31, 2013 -14.41%
Dec 31, 2012 25.94%
Sep 30, 2012 -6.11%
Jun 30, 2012 5.27%
Dec 31, 2011 -28.03%